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The mechanisms mediating the varied effects of ultra-
violet radiation (UVR) on human skin are unclear, al-
though a relationship between erythema and DNA 
damage is suggested by photosensitivity in xeroderma 
pigmentosum. Increased p53 expression in response to 
UVR is thought to reflect direct DNA damage, but 
recent evidence indicates that UVR also activates 
l'I1embrane and cytosolic signal transduction path-
'Ways. In this study, we have investigated the relation-
ship between erythema and p53 induction following 
UVB and whether this p53 response is specific to UVR. 
p53 protein expression was determined by immunocy-
tochemistry using the monoclonal antibody D07, and 
p53 mRNA expression was examined by non-isotopic 
in situ hybridization. Incremental doses of UVB were 
administered to the lower back of eight subjects. Im-
l'I1unostaining revealed that p53 positive nuclei were 
significantly increased 8 h after suberythemogenic 
doses ofUVB (79 ± 12), compared to normal unirra-
T he p53 tumor suppressor gene encodes for a 53-kD phospho-nucleoprotein that can specifically bind DNA, activate transcription, and regulate cell-cycle progression by arresting cells in late G 1 [1,2]. Loss of p53 function, through gene mutation, allele loss, or 
binding of oncoproteins, e.g., MDM2, is a significant step in the 
development of neoplasia [1,3]. Upregulation of p53 protein in 
response to ultraviolet radiation (UVR) was first reported by Maltz-
m.an and Czyzyk in 1984 in non-transformed murine fibroblasts, 
and was shown to occur through a post-translational mechanism (4). 
Similarly, other cellular DNA damaging agents, e.g., cisplatin, mi-
tomycin C, etoposide, and actinomycin D, increase p53 protein 
levels by increasing protein stability, and y and UV radiation can 
increase p53 protein levels in cells, while causing a decrease in 
p53-specific mRNA [5]. On the other hand, induction of p53 pro-
tein was accompanied by increased p53 mRNA in quiescient 3T3 
fibroblasts following serum stimulation [6]. 
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diated skin (8 ± 6, P < 0.0005), but no change in p53 
mRNA was seen. Higher UVB doses, which resulted in 
moderate erythema, resulted in a similar or greater 
induction of p53 protein. Indomethacin (1 % w Iv), ap-
plied immediately after UVB irradiation, signifi-
cantly inhibited UVB erythema at 8 h in six subjects 
(p < 0.005), but did not reduce p53 immunostaining. 
Dithranol (1 j.lg/pJ, n = 8), sodium dodecylsulphate 
(5%, n = 4), and retinoic acid (0.5%, n = 4), applied for 
48 h, caused erythema, significantly increased p53 
protein levels (p < 0.05), and also increased p53 
mRNA. Our results show that in human skin, UVB-in-
duced p53 elevation can be dissociated from erythema 
and skin irritants can also induce p53 protein. The in-
duction of p53 mRNA by irritants but not UVR sug-
gests different mechanisms of action. Keywords: immu-
nocytochemistry/in situ hybridization/Western blotting/ 
dithranol.] Invest DermatoI103:493-499, 1994 
UVR exerts a variety of effects on cells and human skin including 
acute and delayed erythema, immediate and delayed tanning, and 
proliferation responses [7] . Increased cumulative exposure to UVR 
is associated with an increased incidence of non-melanoma skin 
cancer (NMSC) [8]. Induction of p53 expression in nonnal human 
skin in vivo following exposure to simulated solar radiation was first 
reported by Hall et al [9]. Subsequently, the pattern of p53 induction 
ill vivo in human skin was shown to be wavelength specific (10). 
UVR can cause DNA photoproducts in the p53 gene, e.g., cyclobu-
tane dimers and 6-4 photoproducts, both at codons frequently mu-
tated in NMSC, and at codons where mutations have not been 
identified [1 t]. Somatic mutations in the p53 tumor suppressor gene 
specific to UVR, e.g., CC ~ IT double base transitions, have been 
identified in NMSCs, as have other mutations, e.g., C ~ T base 
substitutions, which are likely to be due to UVR [12,13] . The 
mechanism of p53 induction by UVR is poorly understood but 
probably relates to post-translational stabilization [4,5] and al-
though this may be due to a direct DNA damaging effect ofUVR, 
other signal-transduction pathways may also be involved. Protein 
kinase C (PKC) has recently been implicated in the pathways in-
volved in induction of p53 post-ionizing and UVB radiation 
[14,15]. UVR can cause lipid peroxidation ofliposomal membranes 
and lipid peroxidation products have been shown to increase in 
human skin with increasing exposure to UVR [16,17] . Devary et al 
have identified the activation of Src tyrosine kinases as the earliest 
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detectable step in the induction of c-jun by UVR and thus suggested 
that the UV response is initiated by oxidative stress at or near the 
plasma membrane, rather than in the nucleus [18]. It was subse-
quently shown that induction ofNFKB following UVR, as part of 
the UV response, occurs in enucleated cells and, therefore, does not 
require a signal generated in the nucleus [19]. 
In human skin, UVR-induced erythema may be quantified by the 
use of a reflectance instrument and wavelength-specific dose-re-
sponse curves have been observed [20]' Whether a direct relation-
ship between erythema and DNA damage exists is unclear, but this 
is suggested by the increased photosensitivity observed in xero-
derma pigmentosum patients [21]. On the other hand, the pathways 
mediating the initial stages of acute UVR-induced inflammation 
involve arachidonic acid release from membrane phospholipids and 
its subsequent metabolism via the cyclooxygenase system to prosta-
glandins [22,23]. Topical indomethacin (a potent cyclooxygenase 
inhibitor) has been shown to significantly reduce acute UVB-in-
duced erythema [24,25]. In this study, we have investigated the 
relationship between acute UVB erythema and p53 protein and 
mRNA levels to address whether signal-transduction pathways in-
volved in the acute erythema response are also involved ill the in-
duction of p53. We have also addressed whether other irritants that 
cause erythema in skin induce p53 expression. 
MATERIALS AND METHODS 
Subjects Investigations were carried out on the healthy skin of the lower 
back of24 adult volunteers (17 male, 7 female) ages 21 to 81 years, mean age 
57 years. All volunteers gave written informed consent. Exclusion criteria 
included a past history of photosensitivity and any regular oral medication. 
UV Irradiation The UVB source was an irradiation monochromator 
(Applied Photophysics Limited, Surrey, UK, Model UV90) optically cou-
pled to a high-pressure xenon arc lamp, with a central wavelength of300 nm 
and band width of ±5 nm. The diameter of the radiation beam was 10 mm. 
Twelve doses ofUVB (2.5 -112 mJ/cm2, .fi increments) were adminis-
tered to the lower back' of eight volunteers. At 8 h, erythema intensities were 
measured using a reflectance instrument and a visual assessment of the mini-
mal erythemal dose (MED) was also made. UVB-induced erythema is maxi-
mal between 8 and 12 h post-irradiation [26,27]. Biopsies were taken from 
normal unirradiated skin (n = 8), UVB-irradiated skin with no visually 
perceptible erythema (sub-MED, n = 8), and UVB-irradiated skin with an 
erythema index nearest to 0.1 above baseline, equivalent to moderate ery-
thema (n = 4). 
Two series of seven doses ofUVB (14-112 mJ/cm2,.fi increments) were 
administered to the lower back of six volunteers. Immediately after irradia-
tion, indomethacin (1 % w Iv) was applied, under occlusion, at a surface 
density of 200 Jig/cm2, to one set of incremental doses and the gel base 
applied, under occlusion, to the other set. The occlusive patches were re-
moved at 2 h and any residual topical agent allowed to dry. At 8 h, erythema 
intensities were recorded using a reflectance instrument. The gel site that 
gave an erythema index nearest to 0.1 above baseline and the indomethacin 
site that had received the same dose of UVB were identified and biopsies 
taken from these two sites. 
Application of Irritants Twenty-microliter aliquots of a) dithranol (1 
Jig/Jil) in chloroform, b) sodium dodecylsulphate (SDS) (5%) in propylene 
glycol/ethanol (30 : 70), c) retinoic acid (RA) (0.5%) in propylene glycol/ 
ethanol (30: 70), and d) propylene glycol in ethanol (30 : 70) (PG) were 
applied, using Finn chambers, to the skin of the lower back of four volun-
teers. Finn chambers were removed at 48 h, erythema assessed 20 min later 
using a reflectance instrument and biopsies taken from each of the four sites. 
In four other volunteers, dithranol (1 Jig/ Jil) in chloroform, chloroform, 
PG, and a dry filter disk were applied under Finn chambers for 48 h and in 
two additional volunteers dithranol, SDS, RA, and a dry filter disk were 
applied as above for 8 h. Erythema indices were assessed and biopsies per-
formed at these time points. 
Biopsy Proceedure Four-millimeter punch biopsies were performed 
under local anesthesia, immediately fixed in para formaldehyde for 3 hand 
embedded in paraffin. Samples from the same individual were embedded in 
the one paraffin block to minimize variation during immunocytochemical 
and in situ hybridization procedures. 
Immunocytochemistry Four-micrometer sections were immunos-
tained with 007 (a mouse monoclonal antibody against recombinant 
human p53; Novocastra Laboratories Ltd., Newcastle, UK), for 30 min at 
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room temperature, after prior incubation for 10 min with normal rabbit 
serum. Sections were st.1ined both with and without prior antigen retrieval 
by microwaving the sections for 10 min in sodium citrate buffer (pH 6.0) in a 
600-watt conventional microwave oven [28]. After incubating for 30 min 
with a biotinylated rabbit anti-mouse antibody, a streptavidin-biotin-perox-
idase detection system (Dako) was employed with diaminobenzidine (DAB) 
as the substrate. The number of positively stained epidermal nuclei in four 
high-power fields (HPF) was assessed by an independent observer who was 
unaware of the treatment conditions. Hematoxylin and eosin staining was 
also performed on all biopsy specimens. 
Western Blotting Biopsies were finely minced, frozen in liquid N 2, and 
ground to a fine powder. Protein extraction buffer (150 mM NaCI, 50 mM 
Tris, pH 8.0, 5 mM ethylenediaminetetraacetic acid, 1 % NP40, I mM ph en-
ylmethylsulfonyl fluoride) was added. Following sonication for 1 min, sam-
ples were left on ice for 30 min, centrifuged at 15,000 X g for 30 min and the 
supernatant (protein) transfered to a fresh tube. Samples were stored at 
-20°C until required. Protein concentration was measured spectrophoto-
metrically (Pierce BCA Protein Assay Reagent). Three to five micrograms of 
total protein was separated by gel electrophoresis (5% stacking gel, 10% 
running gel) and blotted onto nitrocellulose membrane. Membranes were 
blocked for 1 h at room temperature with 5% nonfat milk/0.2% Tween 20 
and incubated sequcntially with D07 supernatant (5 - 25 Jig/ml) and rabbit 
anti-mouse pcroxidase-conjugated secondary antibody. The peroxidase re-
action was developed using ECL (Amersham). A colonic carcinoma cell line 
(HT29) with a p53 mutation at codon 273, causing an Arg -+ His substitu-
tion, served as a positive control [29]. 
Keratinocyte Cultures Human foreskin keratinocytes were isolated as 
described [30] and were grown in serum-free keratinocyte medium 
(GIBCO) at 37"C in a 95% air/5% CO2 humidified incubator. Cells at 
passage 2 were irradiated for 3 min with a broad band UVB source [31] 
(Wolff Helarium B 1-01-40W, Kosmedico, Stuttgart, Germany) equivalent 
to a UVB dose of 87 mJ/cm2 , and protein was extracted 3 h later using 
protein extraction buffer as described above. 
Probe Preparation Antisense and sense digoxigenin-Iabeled cRNA tran-
scripts were generated from the 1800 base pair (bp) p53 cDNA clone pBSK-
SN3 [32] using a Digoxigenin RNA Labeling Kit (Boehringer Mannheim), 
according to the manufacturer's instructions. Full-length transcripts were 
hydrolyzed to average lengths of 300 bp, prior to recovery by ethanol pre-
cipitation. 
III Situ Hybridization Four-micrometer paraffin sections were subject to 
ill situ hybridization as previously described [33]. Briefly, sections were 
pretreated with 5-Jig/ml proteinase K (Boehringer Mannheim)/O.l M Tris-
HCI, pH 8.0; 50 mM ethylenediaminetetraacetic acid, at 37"C for 15 min, 
immersed in 0.2% glycine for 5 min, and rinsed in 300 mM NaCl, 30 mM 
sodium citrate (2 X SSC). Following pre hybridization (60 min at 42°C), 30 
Jil of hybridization buffer (4 X SSC, I X Denhardt's solution, 50% deion-
ized formamide, and 100 Jig/ml each of denatured salmon sperm DNA and 
Escherichia coli transfer RNA) containing 20 ng of digoxigenin-Iabeled 
cRNA probe was applied to each section. Adjacent sections were hybridized 
with antisense and sense probes. Following hybridization, slides were 
washed to a final stringency of 0.1 X SSC/50% formamide at 45· C. Fol-
lowing a 2 X SSC rinse, digoxigenin-Iabeled hybrids were immunologically 
detected using a Digoxigenin Nucleic Acid Detection Kit (Boehringer 
Mannheim), according to the manufacturer's instructions. Slides were mon-
itored for colormetric development, which was stopped in TE buffer (10 
mM Tris, I mM ethylenediaminetetraacetic acid; pH 7.4). 
Statistics Summary statistics are reported as means ± SEM. Comparisons 
between means were performed using unpaired or paired t tests as appropri-
ate. The data was analyzed using microstat software (Ecosoft Inc). 
RESULTS 
Effect of UVB Irradiation on p53 Protein Expression in 
Human Skin p53 protein expression was assessed by immunocy-
tochemistry in skin 8 h following irradiation with erythemogenic 
and suberythemogenic doses of UVB. Doses of UVB received by 
the sub-MED biopsy sites ranged from 10 to 40 mJ/cm2 (MED 
14-56 mJ/cm2) (Table I). The absolute erythema indices con-
curred with the absence of visible erythema, with no significant 
difference between normal and sub-MED erythema indices (p = 
0.36). The number of p53-positive nuclei/HPF was significantly 
increased in sub-MED skin (79 ± 12) compared to normal unirra-
diated skin (8 ± 6, P = 0 .0003) (Figs 1 and 2). p53 staining was 
entirely nuclear with no cytoplasmic staining and was evenly dis-
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Table I. Summary of p53 Protein and p53 mRNA Expression in UVB-Irradiated Subjects" 
MED SubMED 0.1 EI 
p53 Protein (nucleifHPF) and mRNA 
Subject Age/Sex (mJ/cm2 ) (mJ/cm2 ) (mJ/cm2 ) Normal SubMED 0.1 EI Gel Indomethacin 
1 73/F 28 20 5/+ 66/+ 
2 68/F 28 20 48/+ 102/+ 
3 21/F 56 40 1/+ 58/+ 
4 73/F 28 20 5/+ 89/+ 
5 63/M 28 20 40 0/+ 117/+ 120/+ 
6 22/M 28 20 56 0/+ 53/+ 62/+ 
7 52/M 14 10 28 2/+ 25/+ 138/+ 
8 21/M 28 20 80 5/ND 122/ND 220/ND 
9 63/F 28 28 167/+ 167/+ 
10 40/M 20 28 94/+ 107/+ 
11 70/M 28 28 53/+ 56/+ 
12 46/F 112b 14 38/+ 27/+ 
13 38/M 28 28 195/+ 196/+ 
14 76/M 28 40 112/+ 130/+ 
• Levels of expression of p53 protein (positive nuclei per Iligh power field) and p53 mRNA (graded +/++/+++). ND indicates not done. 
• This subject was pigmented prior to irradiation. SubMED and 0.1 EI are as described in Fig 1. Gel and indomethacin are as described in Fig 4. 
tributed throughout the epidermis, in all cases, following UVB 
irradiation. Fibroblasts in the upper dermis also stained positive in 
most cases following irradiation. Prior microwaving of tissue sec-
tions caused increased intensity of positive staining and gave slightly 
higher counts per HPF in irradiated cases, but did not alter the low 
numbers of positively stained nuclei in unirradiated skin. Doses of 
UVB sufficient to cause an increase in the erythema index of 0.1 
above baseline in four volunteers ranged from 28 to 80 mJjcm2 • 
Two patterns of p53 induction were observed in the biopsies of 
sub-MED and moderately erythematous skin in these four subjects 
(Table I). In two volunteers, the number of p53-positive nucleij 
HPF in both the sub-MED skin (53 and 117) and the irradiated skin 
with an erythema index of 0.1 above baseline (62 and 120, respec-
tively) were similar. In two other subjects, the number of p53 nu-
ciei j HPF increased in proportion to the UVB dose received (122 at 
20 mJ jcm2 and 220 at 80 mJjcm2 for one subject and 25 at 10 
mJ jcm2 and 138 at 28 mJjcm2 for the other). 
To ensure that the increase in p53 immunostaining in response to 
UVR was due to increased p53 protein, we performed Western 
blotting. Figure 3 demonstrates an increase in the intensity of the 
53-kDa (p53) band following UVB irradiation of human skin and 
cultured human keratinocytes. 
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Figure 1. Dissociation of erythema and p53 protein expression in 
hu.rnan skin following UVB irradiation. a) Erythema index and b) 
number of p53 immuno-positive epidermal nuclei per HPF in normal skin 
and 8 h after UVB irradiation (SubMED, skin with no detectable erythema 
that had received one dose below the MED; 0.1 EI, skin that had received 
dose sufficient to increase the erythema index 0.1 above baseline). Immu-
nostaining using D07 anti-p53 antibody was carried out as described in 
Materials alld Methods. All values arc means ± SEM, • n = 4, +n = 8. 
Effect of UVB Irradiation on p53 mRNA Expression in 
Human Skin In situ hybridization, using a digoxigenin-labeled 
antisense p53 cRNA probe, showed positive cytoplasmic signal in 
the lower layers of the supra basal epidermis of normal unirradiated 
skin, with 10-20% of basal cells also being positive. At 8 h post-
UVB irradiation a small increase in the number of p53 in situ hy-
bridization positive basal cells was observed in skin with an ery-
thema index of 0.1 above baseline, whereas no changes were 
identified in the sub-MED biopsies (Table I). No increase in the 
signal was seen in the suprabasal compartment post-irradiation in 
spite of the changes in immunocytochemistry. For each sample, 
specificity of hybridization was confirmed using sense-strand and 
unrelated probe (keratin 14) controls, as previously described [33]. 
Effect of Indomethacin on UVB-Induced p53 Protein Ex-
pression in Human Skin We next examined whether inhibi-
tion ofUVB-erythema affects p53 expression in human skin. Doses 
ofUVB sufficient to cause an increased erythema index of 0.1 above 
baseline at 8 h ranged from 14 to 40 mJjcm2 in six volunteers 
(Table I). Indomethacin significantly inhibited UVB-erythema 
compared to control (75 ± 16% reduction, p = 0.0014). Positive 
p53 immunostaining was observed in all 12 biopsies at 8 h post-irra-
diation. The mean number of p53-positive nucleijHPF was 110 ± 
25 for the UVBjgel-treated skin and 114 ± 26 for the UVBjindo-
methacin-treated skin. Thus although indomethacin significantly 
inhibited UVB erythema, indomethacin failed to inhibit induction 
of p53 by UVB (Fig 4). No significant change in p53 mRNA level 
and distribution was identified following the application of indo-
methacin. 
Effect of Irritants on p53 Protein Expression in Human 
Skin We then investigated whether other erythemogenic agents 
also induce p53 expression in human skin. At 48 h after the applica-
tion of irritants, epidermal nuclear p53 protein was detected in all 
irritant biopsy specimens. The mean number of p53-positive nuclei 
per HPF was 46 ± 14 for dithranol, 59 ± 29 for SDS, 55 ± 31 for 
RA, 37 ± 13 for PG, 36 ± 18 for chloroform, and 17 ± 25 for 
normal skin. The pattern of p53 induction was evenly distributed 
throughout the epidermis for all irritants but individuals showed 
different sensitivities to the different substances. The increase in 
p53-positive nucleijHPF was significant for dithranol, SDS, and 
RA compared to normal untreated skin (p < 0.05). In general, the 
intensity of staining was greater in UVB-treated skin, even at 
subMED doses, than in irritant-treated skin. The mean increase in 
the erythema indices were 0.192 ± 0.014 for dithranol, 0.121 ± 
0.025 for SDS, 0.054 ± 0.017 for RA, 0.009 ± 0.004 for PG, and 
0.034 ± 0.012 for chloroform. No relationship was detected be-
tween the number of p53-positive nuclei per HPF and the increase 
ill erythema index following the application of irritants. 
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Figure 2. Increased p53 immunostaining folIowing suberythemo-
genic and moderately erythmogenic doses of UVB in human skin. 
Irradiation of human skin was carried out as in Fig 1. Immunostaining using 
007 anti-p53 antibody was carried out as described in Materials atld Methods. 
a) Normal unirradiated skin, b) SubMEO, and c) 0.1 EI from one subject. 
Scale bars, 12.5 J1.m . 
In the two volunteers biopsied at 8 h after application of the 
irritants, an increase in the number of epidermal p53-positive nuclei 
per HPF was observed in dithranol-treated skin (46 and 40) as com-
pared with normal occluded skin (9 and 0) (Fig 5a,b). An increase 
was also observed in SDS- and RA-treated skin at 8 h in one volun-
teer (69: 49 : 9 for SDS : RA: normal occluded) but there was no p53 
protein detected in the corresponding biopsies from the second vol-
unteer. 
Effect of Irritants on p53 mRNA in Human Skin As com-
pared with normal untreated epidermis, a large increase in the in-
tensity of signal and the number of both basal and suprabasal posi-
tive cells, as detected by il1 situ hybridization, was observed at 8 and 
48 h following application of dithranol, SDS, and RA. Individuals 
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Figure 3. Western blot analysis of p53 protein expression in (A) 
human skin and (B) cultured human keratinocytes. Western blotting 
using 007 anti-p53 antibody was performed as described in Materials atld 
Methods. A) M, markers (EeL, Amersham), from top to bottom 97.4, 68, 46, 
31,20.1, and 14.4 kOa. Latle 1, human skin at 8 h after irradiation with 
moderately erythemogenic dose of UVB (112 mJ/cm2); latle 2, normal 
unirradiated human skin. B) Latle 1, normal unirradiated cultured human 
keratinocytes; latle 2, cultured human keratinocytes at 3 h after irradiation 
with 3 min of a broad band UVB source [31) (WolffHeiarium BI-01-40W, 
Kosmedico, Stuttgart, Germany) equivalent to a UVB dose of 87 mJ/cm2; 
C, positive control (HT29 colonic carcinoma cell line). 
varied in their senSitiVity to these irritants although dithranol 
caused a consistent increase in p53 mRNA in all cases (Fig 5c,/). 
DISCUSSION 
p53 is a tumor suppressor gene, functioning as a "guardian of the 
genome" by causing cells to arrest in late G 1 following exposure to 
energy-rich radiation, e.g., y-radiation [34]. The high incidence of 
mutations of this gene in NMSC suggests that it plays an important 
physiologic role in the skin [12,13], and the induction of wild-type 
p53 in human epidermis in response to UVR is likely to be relevant 
in the prevention of skin carcinogenesis. Although DNA damage by 
cytotoxic agents, e.g., cisplatin, mitomycin C, etoposide, and actin-
omycin D, causes post-translational stabilization of p53 protein [5]. 
the site of initiation of p53 induction by UVR is not well estab-
lished. UVR causes a wide variety of responses including erythema 
[7). We therefore investigated whether a relationship existed be-
tween erythema and p53 induction in human skin following UVB 
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Figure 4. UVB-induced erythema but not p53 protein expression is 
reduced by topical indomethacin in human skin. Irradiation of human 
skin was carried out as in Fig 1, with application of indomethacin or gel 
immediately after irradiation. Immunostaining using 007 anti-p53 anti-
body was carried out as described in Materials and Methods . a) Increase in 
erythema index above baseline and b) number of p53 immune-positive epi-
dermal nuclei per HPF, following doses of UVB sufficient to cause an 
increase in the erythema index of 0.1 above baseline at the gel site (UVB/ 
gel) with same doses applied to the indomethacin site (UVB/indo). Values 
are means ± SEM, n = 6. 
VOL. 103, NO.4 OCTOBER 1994 p53 EXPRESSION AND ERYTHEMA 497 
a 
- b 
-
e 
-
f 
-
Figure 5. Increased p53 protein and mRNA expression in human skin following application of dithranol for 8 h. Immunostaining using 007 
anti-p53 antibody and ill situ hybridization using a digioxigenin-labeled cRNA probe complementary to p53 mRN A was performed as described in Materials 
and Methods. Photomicrographs show a) p53 protein in normal untreated skin, b) p53 protein in dithranol-treated skin, c) p53 mRNA in normal untreated skin, 
and d) p53 mRNA in dithranol-treated skin. No significant difference in keratin 14 ill situ hybridization signal was observcd betwecJ{ nonnal (e) and 
dithranol-treated skin (J). Scale bars, 12.5 jlm. 
and whether other erythemogenic agents were capable of inducing 
p53. 
The erythema response is widely used as a measure ofuv expo-
sure and indirectly as a risk factor for NMSC in human skin [35]. 
Hall et al demonstrated an increase in p53 protein levels using doses 
of solar simulated radiation sufficient to cause erythema equivalent 
to 1.5 MEDs [9]. Campbell el al compared equi-moderately erythe-
mogenic doses ofUVA, UVB, and UVC, and demonstrated a wave-
length-specific pattern of p53 induction [10]. A large increase in 
p53 protein levels in human skin post- UVB irradiation, at a dose 
sufficient to cause an increase in the erythema index of 0.1, was 
observed in this study using both immunocytochemistry and West-
ern blotting. Thus, Western blotting confirmed that the D07 anti-
body binds to increased amounts to p53 protein following UVB 
irradiation and also shows that the increased immunocytochemistry 
staining observed is not due to non-specific binding of the antibody 
to another antigen that might have become altered or unmasked 
after exposure to UVB. However, as our results show, doses ofUVB 
that do not cause erythema (both on visual and reflectance instru-
ment assessment), cause a significant increase in p53 protein levels 
in human epidermal cells. At these suberythemogenic doses ofUVB 
the pattern of induction of p53 protein was evenly distributed 
throughout the epidermis as in the case of moderately erythemo-
genic doses. If DNA injury is a prerequisite for induction of p53, 
these results suggest that significant epidermal nuclear damage 
occurs at low doses ofUVB and highlight the importance of physi-
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ologic non-erythemogenic doses ofUVB, i.e., doses ofUVB below 
that which causes sunburn, in skin carcinogenesis. Although low 
doses ofUVC are capable of causing photoproducts in the p53 gene 
in vitro [11], whether low sub-erythemogenic doses of UV13 can 
cause similar changes in the p53 gene in vivo is, at present, unknown. 
Interestingly, in two of the four subjects in whom biopsies were 
taken from subMED and moderately erythematous skin, the num-
ber of p53-positive nuclei per HPF was similar for both doses of 
UVE. In the other two cases, a greater number of p53-positive 
epidermal nuclei were identified at the higher UVB dose. This 
inter-subject variation may be important in the protection offered to 
the cell against the subsequent development of neoplasia, and there-
fore for individual risk. The reason for p53 upregulation in the 
cycling cells of the basal and lower suprabasal layers is obvious in 
this regard, but not so obvious for cells in the upper stratum spino-
sum. The participation of p53 in the initiation of apoptosis might be 
more relevant here, yet hematoxylin and eosin staining showed 
only one to two apoptotic cells/HPF in skin biopsies with an ery-
thema index of 0.1 above baseline in contrast to the dramatic 
increase in the number of p53-positive nuclei throughout the 
epidermis. 
The acute erythema response following UVB involves release of 
arachidonic acid from the cell membrane and its subsequent metab-
olism by the cyclo-oxygenase pathway [22,23]. Indomethacin is a 
potent inhibitor of cyclooxygenase and has been shown to cause 
significant suppression of acute-phase UVB-induced erythema 
when applied topically to human skin [24,25]. Arachidonic acid can 
stimulate activation of the PKC signal-transduction system, and 
activation of PKC further increases the release of arachidonic acid 
from phospholipids [36]. TPA and calphostin C modulate the in-
duction of p53 in murine fibroblasts and ataxia-telangiectasia cells 
respectively following ionizing and UVB radiation, suggesting that 
PKC may be involved in this process [14,15]. In this study, topical 
indomethacin significantly inhibited UVB-induced erythema, but 
failed to alter UVB induction of p53 protein, suggesting that prod-
ucts of the cyclo-oxygenase pathway are not involved in p53 induc-
tion post-UVB. These data together with our observation of p53 
induction with suberythemogenic doses of UVB indicate that in-
creased p53 expression following UVB irradiation may be disso-
ciated from UVB-induced erythema and suggests that these events 
are mediated by different signal-transduction pathways. 
The mechanism of increased p53 protein expression after UVR 
was originally investigated by Maltzman and Czyzyk using UVC in 
non-transformed murine fibroblasts and was shown to be, in part, 
due to post-translational stabilization [4]. Fritsche et al confirmed 
increased p53 protein stability following UVR but also demon-
strated ongoing p53 translation [5]. Smith and Rees have demon-
strated that p53 mRNA levels in human skin do not differ from 
baseline at 24 and 48 h after UVR [33]. Our results using in situ 
hybridization show no increase in p53 mRNA levels in the supraba-
sal epidermis and minor increases in the signal in the basal epidermis 
at 8 h and provide further evidence that induction of p53 protein in 
human skin post-UVR occurs predominantly at a post-transcrip-
tional stage. 
The significant increase in p53 protein levels in human skin ob-
served following application of dithranol, SDS, and RA suggest that 
up-regulation of p53 maybe a non-specific response ofkeratinocytes 
to noxious stimuli. Although all these agents have the ability to 
cause skin irritation, they differ in the intracellular pathways 
through which their effects are mediated and may differ in their 
mechanism of p53 mRNA induction. Although dithranol may 
cause DNA damage via oxidative stress [37], and RA can act indi-
rectly on DNA via members of the retinoic acid receptor (RAR) and 
RXR families to effect gene transcription [38,39], the mechanism of 
{'53 induction by SDS is unclear. PKC phosphorylates p53 protein 
[40], and modulates the induction of p53 after ionizing and UVB 
radiation [14,15], and dithranol is known to inhibit PKC in vitro 
[41]. Thus, it is possible that activation of cell membrane and cyto-
solic signal-transduction pathways may be responsible for the p53 
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induction observed with skin irritants. The fact that no relationship 
was detected between the number of p53-positive nuclei/HPF and 
the increase in erythema index following the application of these 
irritants further confirms that products of the cyclooxygenase path-
way are unlikely to be involved in p53 protein induction, but does 
not rule out the possible involvement of other cell membrane 
events. 
Our in situ hybridization results on irritant-treated skin showed 
an increase in p53 mRNA at both 8 and 48 h post-application and 
are therefore of particular interest. This result is in contrast to the 
absence of p53 mRNA induction following UVR and shows that 
different mechanisms may account for increasing p53 protein in vivo 
in response to various stimuli. That different mechanisms operate in 
vivo to upregulate p53 protein suggests that this induction is not 
merely a non-specific response of keratinocytes to all noxious stim-
uli. 
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